Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN ICD-9-CM Coding Request Extravasation of Vesicant Chemotherapy.

Slides:



Advertisements
Similar presentations
IV INSERTION HOME CARE. Intravenous (IV) Medications enter the patients bloodstream directly by way of a vein Appropriate when: – rapid effect is required.
Advertisements

Infection Control: IV Drug Administration
Medication Administration
Chapter 15 Infusion Therapy.
Kristen Bodnaruk, RN, BS Denise Dreher, RN, CRNI, VA-BC
INTRAVENOUS THERAPY Bc. Marie Bártová Institute of Nursing Theory and Practice Charles University, 1 st Faculty of Medicine Prague 2007.
Public Health Issues Related to Mutually Conforming Labeling: CDRH Perspective Miriam C. Provost, Ph.D. Office of Device Evaluation Center for Devices.
CANNULATION & VENESECTION. LEARNING OUTCOMES OF THE WORKSHOP To be able to assess the patient To be able to assess the patient To be able to take a blood.
LHS IV Resource January 2008 PCM Presentation Jacqueline Bowns RN IVRS/WOCN Supervisor.
Extravasation of Chemotherapeutic Agents
Infusion Therapy.
Extravasation of Intravenous Non-Chemotherapeutic Agents
Research Aims Method Background Results Conclusions Sixteen articles met inclusion criteria Fifteen articles were selected for review Articles provided.
Fundamental Nursing Chapter 16 Fluid and Chemical Balance Inst.: Dr. Ashraf El - Jedi.
Fundamental Nursing Chapter 35 Intravenous Medications
The Development and Implementation of a
 Introduced in early 1980s  Allow medications to be delivered directly into larger veins  Less likely to clot  Can be left in for longer periods of.
Rationale Review of Literature Background PICO Question The high risk obstetric patient have prolonged hospitalizations Many of our patients require a.
Starting a Peripheral IV Principles of IV Therapy BSN336 Lab.
How and Why Drugs Work Chapter 5
A stroke is the leading cause of permanent impairment and disability. Pending a radical cure, patients recovering from a stroke will continue to require.
NORTH AMERICAN SAFETY CHECKLIST – SB 158. Rhonda Anderson, RHIA President Anderson Health Information Systems, Inc. Presented By:
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Molecular Pharmacology.
Use of Animals in Research
Smart Device Integration
Different Types of IV and Dialysis Accesses
Copyright ©2012 by Pearson Education, Inc. All rights reserved. Emergency Care, Twelfth Edition Limmer O’Keefe Dickinson Introduction to Emergency Medical.
Originally Created By: Sheila Elliott MN, RN Revised By: Tina Haayer, RN, BScN.
Extravasation Management of Non-Chemotherapeutic Agents
 Hub (IV catheter)  Maintenance (or primary) solution  TKO (KVO) rate  Parenteral  Mechanical gravity devices  EID: electronic infusion device 
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
Principles of Medication Administration and Medication Safety Chapter 7 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of.
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 35 Intravenous Medications.
Infusion Therapy.
Informed Consent Part 1: General Principles Part 2: Risks and Alternatives Related to Central Venous Catheter Insertion Office of Graduate Medical Education.
RE/P HARM -C HAPTERS 3 & 4 Intravenous Drug Therapy & Dose Calculation.
Shock and Multisystem Failure
Arterial Line. Outline Definition. Indication Contraindication. EQUIPMENT Arterial Sites Nursing Skills Standard.
Intravenous cannulation
Medical-Surgical Nursing: An Integrated Approach, 2E Chapter 11 IV Therapy.
Background ______________________________
RAPID RESPONSE SERVICE Catriona Briers Lead Nurse Rapid Response Service Making Life Better Mossley Mill, Newtownabbey 4 th March 2016.
IV Therapy Vema Sweitzer, MN,RN.
Chapter 31 Medication Administration. Injections: Intravenous  Three methods:  As mixtures within large volumes of IV fluids  By injection of a bolus.
©ECRI XIX. Drug Delivery Pumps TRAINING SEMINAR ON MEDICAL DEVICE ACCIDENT INVESTIGATION for Kingdom of Saudi Arabia Saudi Food & Drug Authority.
Chapter 16 Fluid and Chemical Balance
A stroke is the leading cause of permanent impairment and disability
Presentation On Routes of drug administration & it’s significance
Mary Alexander, MA, RN, CRNI®, CAE, FAAN Chief Executive Officer
Chapter 16 Fluid and Chemical Balance
Chapter 16 Fluid and Chemical Balance
Fundamental Nursing Chapter 35 Intravenous Medications
Nursing Care of Patients Receiving IV Therapy
الاحتراق.
Chapter 35 Intravenous Medications
Intravenous Therapy Complications
Ports TIVAD/P (totally implanted venous access device/port)
Chapter 6: Dosages of IV Drugs
Fundamental Nursing Chapter 35 Intravenous Medications
Swollen Hand Annals of Emergency Medicine
Fundamental Nursing Chapter 16 Fluid and Chemical Balance
GRANULOCYTES ABO compatibility:
Unit 3 – Chemical Reactions
Chapter 35: Intravenous Medications
Considerations for Device Selection xxxxx | Clinical Specialist
TMEM-mediated vascular permeability is transient and localized.
Presentation transcript:

Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN ICD-9-CM Coding Request Extravasation of Vesicant Chemotherapy

Extravasation “the act of passing out of a vessel or organ”

Intravenous (IV) chemotherapy drugs Vesicants: have the potential to cause a chemical burn if they inadvertently go into the tissue Non-vesicants: do not cause tissue damage

Two considerations 1) Complication: extravasation into the tissue 2) Substance being infused: vesicant chemotherapy

Extravasation of vesicant chemotherapy May occur when: --IV catheters dislodge --IV catheters leak --IV devices break or malfunction Code 996.1, mechanical complication of other vascular device, implant, or graft Encompasses complication, but not substance being infused.

Extravasation of vesicant chemotherapy May occur when: ---needles are incompletely placed into implanted ports ---needles dislodge from implanted ports Vesicant inadvertently infuses into tissue. Not a device complication (996.1) and not a vascular complication (999.2 other vascular complications).

Extravasation of vesicant chemotherapy Has occurred when: ---vesicants intended for IV administration have inadvertently been given IM or SQ Not a device complication and not a vascular complication.

Extravasations of vesicant chemotherapy are chemical burns of the tissue that occur as a result of various causes.

999 Complications of medical care, NEC 999.8_ Other complications of transfusions and infusions Other transfusion reaction (now 999.8) Extravasation of vesicant chemotherapy

“Extravasation of vesicant chemotherapy” ---Terminology used in clinical practice & the literature. ---Accurately reflects the process that is occurring. ---Having a specific, clearly stated code would help CMS collect data about this complication. ---This data could be used to improve clinical practice, promote safety, and enhance quality of care.